Redeye provides an initial comment on Biovica’s Q2 2025/2026 report, which showed slower sales than ...
Västra Hamnen Corporate Finance (Västra Hamnen), an independent financial advisory firm, has initiat...
* Well-positioned within advanced cybersecurity * Financial resilience and profitable growth expecte...
* SEK 58m follow-up order (Terminals) from Swedish FMV * Deliveries start in H1'26 * Supports Termin...
Siljansvik has received a clear short-term catalyst as Rättvik Municipality, already a major shareho...
Atria will invest EUR 23m in the production of meat products at its Sköllersta plant in Sweden.
Redeye returns with additional comments and revisions following AAC Clyde Space’s directed share iss...
Redeye is positive about the regulatory approval in Japan for the next-generation TetraGraph system ...
Redeye comments on the topline data from the phase III study of imlifidase in anti-GBM disease.
Redeye comments on Friday’s press release from Waystream, stating it has secured a big SEK26m order ...
* Raises SEK 26.6m in the rights issue * Reduces working capital needs by up to SEK 30m * Mitigates ...
Redeye comments on Avensia’s November sales figures.
Gofore just announced it is joining forces with an AI-focused niche company, founded by key employee...
Redeye briefly comments on Truecaller releasing an update regarding its Q4 2025 revenue development,...
We expect Q4 to show continued positive momentum, supported by recent trends in key franchises and a...
On 11 December 2025, Hella announced its first series production order for High-Resolution Radar (HR...
The announcement of Nanexa’s first licensing deal marks a meaningful validation of the PharmaShell p...
Smart Eye has successfully issued a SEK300m senior unsecured bond at 3M STIBOR + 7%, which we view a...
Due to longer sales cycles in the UK and Germany, Careium announced its full-year 2025 guidance will...
Redeye comments on Optomed’s directed share issue, raising EUR6.
